Try
Indivior Pharmaceuticals Inc. Common Stock
INDVUnited States
9 filed reports · 554 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
9 reports · Dec 2023 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 4 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 5 | 1,043 | Mar 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 2 | 1,308 | Dec 2024 to Dec 2025 |
| Annual · 20-FSEC EDGAR | 1 | 989 | Dec 2023 |
| Current · 8-KSEC EDGAR | 1 | 2 | Jun 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 3, 2026 | 338 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 3, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | Apr 30, 2026 | 198 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 908 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 30, 2025 | 241 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 31, 2025 | 135 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 1, 2025 | 131 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 3, 2025 | 400 | Open |
| FY2023 | 20-F | Dec 31, 2023 | Mar 6, 2024 | 989 | Open |
Financial data
554 concepts · 3,342 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial529 concepts · 2,979 facts · Dec 2020 to Jul 2026
- Cash cash equivalents restricted cash and restricted cash equivalents18 · Dec 2021 to Jun 2026
- Stockholders equity (US GAAP)18 · Dec 2021 to Jun 2026
- Common stock shares issued15 · Dec 2021 to Jun 2026
- Revenue15 · Dec 2021 to Jun 2026
- Accrued legal and settlement expenses14 · Dec 2022 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value14 · Dec 2022 to Jun 2026
- Allocated share based compensation expense14 · Dec 2022 to Jun 2026
- Asset impairment charges14 · Dec 2022 to Jun 2026
- Comprehensive income net of tax14 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- Deferred income tax expense benefit14 · Dec 2022 to Jun 2026
- Depreciation depletion and amortization14 · Dec 2022 to Jun 2026
- Foreign currency transaction gain loss before tax14 · Dec 2022 to Jun 2026
- Gross profit (US GAAP)14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Increase decrease in accounts receivable14 · Dec 2022 to Jun 2026
- Increase decrease in inventories14 · Dec 2022 to Jun 2026
- Increase decrease in other operating assets14 · Dec 2022 to Jun 2026
- Increase decrease in other operating liabilities14 · Dec 2022 to Jun 2026
- Incremental common shares attributable to share based payment arrangements14 · Dec 2022 to Jun 2026
- Interest expense nonoperating14 · Dec 2022 to Jun 2026
- Investment income interest14 · Dec 2022 to Jun 2026
- Net cash provided by used in financing activities14 · Dec 2022 to Jun 2026
- Net cash provided by used in investing activities14 · Dec 2022 to Jun 2026
Segment20 concepts · 337 facts · Dec 2022 to Jun 2026
- Revenue105 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- Gross profit (US GAAP)14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Interest expense nonoperating14 · Dec 2022 to Jun 2026
- Investment income interest14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Operating expenses (US GAAP)14 · Dec 2022 to Jun 2026
- Operating income loss14 · Dec 2022 to Jun 2026
- Research and development expense excluding acquired in process cost14 · Dec 2022 to Jun 2026
- Selling general and administrative expense14 · Dec 2022 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Depreciation depletion and amortization12 · Dec 2023 to Jun 2026
- Gain loss related to litigation settlement12 · Dec 2022 to Dec 2025
- General and administrative expense (US GAAP)12 · Dec 2022 to Dec 2025
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest12 · Dec 2022 to Jun 2026
- Selling and marketing expense (US GAAP)12 · Dec 2022 to Dec 2025
- Other nonrecurring income expense8 · Dec 2022 to Dec 2025
- Research and development asset acquired other than through business combination written off8 · Dec 2022 to Dec 2025
- Gains losses on extinguishment of debt4 · Mar 2025 to Jun 2026
Product2 concepts · 13 facts · Dec 2021 to Dec 2025
- Revenue12 · Dec 2021 to Dec 2024
- Inventory write down1 · Dec 2025
Geography1 concepts · 9 facts · Dec 2021 to Dec 2023
- Revenue9 · Dec 2021 to Dec 2023
Guidance2 concepts · 4 facts · Aug 2026
- Capital Expenditures Guidance2 · Aug 2026
- Revenue Guidance2 · Aug 2026
Segments
359 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 337 facts
- Reportable337 · Dec 2022 to Jun 2026
Geographical areas3 members · 9 facts
- Countries Other Than U.S. Or U.K.3 · Dec 2021 to Dec 2023
- GB3 · Dec 2021 to Dec 2023
- US3 · Dec 2021 to Dec 2023
Products and services3 members · 9 facts
- Marketed Products PERSERIS3 · Dec 2021 to Dec 2023
- Marketed Products SUBLOCADE3 · Dec 2021 to Dec 2023
- Sublingualother3 · Dec 2021 to Dec 2023
Product or service3 members · 4 facts
- Perseris2 · Dec 2022 to Dec 2023
- Sublingual And Other Onerous Contracts1 · Dec 2024
- Sublocade1 · Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary83 claims from 6 reports · Mar 2025 to Jun 2026
- Management discussion (MD&A) commentary146 claims from 7 reports · Dec 2024 to Jun 2026
- Risk-factor changes39 claims from 1 reports · Dec 2025
- Risk factors124 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 3, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.